Consent to Treatment : A Practical Guide

Consent to Treatment: A Practical Guide, Fourth Edition is the single-volume, complete library of patient consent topics and solutions. Written by an experienced health care attorney and risk manager, this leading resource helps you formulate your own effective, voluntary and lawful consent policies and procedures - so that you can successfully limit liability and avoid litigation. Described as "the Bible" on consent by health lawyers and risk managers and recently reviewed by the Journal of the American Medical Association (JAMA), Consent to Treatment has been cited in over 90 law review articles and 20 court decisions, including a landmark ruling by the U.S. Supreme Court regarding end-of-life choice-making. Consent to Treatment helps you: Formulate and enforce effective consent policies and procedures Navigate consent topics - both common and complex Stay in compliance with state and federal laws on consent Provides solid case analysis on important issues in consent to treatment Use consent strategies to promote patient safety Offers practical risk management insights to mitigate potential for consent litigation And more! Consent to Treatment has been updated to include coverage of the following information: Mississippi's definition of "deceptive" and "misleading" Updates to statutes and cases involving The law of consent Adequate disclosure Negligent consent The duty to warn others of potential harm Patients' requests not to be informed The importance of consent in IVF Mammography Menopausal and postmenopausal treatment The age when a person can legally give consent Psychoactive drugs and other medications Mental health directives Medical and surgical treatment of the mentally disabled The use of force on mentally disabled patients Accessing private information Health Information Exchanges and meaningful use Discussion of the effect a study on outcomes for patients who refuse blood and blood byproducts for religious reasons could have on a health care organization's policies FDA guidance on issues, including consent, to consider when transferring investigation oversight responsibilities New section on regulatory issues in human research and consent Updated requirements for Advance Beneficiary Notice and Advance Beneficiary Notice of Noncoverage Updated discussion of nontreatment situations and consent beyond U.S. borders